Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial.

Nuntakorn ThongtangJirasak PiyapromdeeNatthakan TangkittikasemKittichai SamaithongcharoenNithiwat SrikanchanawatSutin Sriussadaporn

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)

Switching from low-dose statins to high-intensity statins resulted in a significant reduction in plasma LDL-C levels, and was fairly well tolerated during a 12-week study period.

Keyphrases

high intensity
low dose
cardiovascular disease
type diabetes
resistance training
high dose
coronary artery disease
low density lipoprotein
randomized controlled trial
insulin resistance
glycemic control
adipose tissue
clinical trial